HealthcareServices

Liver Disease Diagnostics Market Size and Demand Forecast 2026–2030

February 26, 2026February 26, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the liver disease diagnostics market from 2026–2035 with trusted insights from The Business Research Company

What level of growth is expected in the Liver Disease Diagnostics Market between 2026 and 2030?

The liver disease diagnostics market has experienced significant expansion in recent years. This market is projected to grow from $38.95 billion in 2025 to $41.84 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 7.4%. Historically, this growth has been influenced by factors such as the increasing prevalence of hepatitis infections, rising alcohol consumption patterns, early reliance on blood-based liver tests, the growing incidence of liver cirrhosis, and the expansion of hospital diagnostic infrastructure.

The liver disease diagnostics market is poised for significant expansion in the coming years, with its size projected to reach $55.17 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.2%. This projected growth during the forecast period is primarily driven by the escalating burden of NAFLD and NASH, an increasing public awareness of preventive liver care, the broader adoption of advanced imaging techniques, the proliferation of population health screening programs, and elevated healthcare spending on diagnostics. Key developments expected within this period include a heightened demand for early liver disease detection, the increasing utilization of non-invasive diagnostic methods, more frequent screening for fatty liver and fibrosis, the expansion of routine liver function testing, and a growing clinical focus on monitoring disease progression.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20862&type=smp

Which Drivers Are Expected To Impact The Liver Disease Diagnostics Market During The Forecast Period?

The liver disease diagnostics market is projected to experience growth driven by the rising consumption of alcohol. This increase in alcohol intake is attributed to evolving social norms, enhanced affordability, widespread availability, and a rise in stress or mental health challenges. Liver disease diagnostics play a vital role in monitoring the effects of alcohol consumption on liver health, aiding in the early detection of liver damage indicators such as fatty liver, hepatitis, or cirrhosis. For example, in December 2024, the Bureau of Labor Statistics, a US-based government agency, reported that in 2023, U.S. households spent an average of $294 on alcoholic beverages consumed at home and $343 on those consumed outside the home. Hence, the observed increase in alcohol consumption is a key factor propelling the expansion of the liver disease diagnostics market.

Which Segments Are Driving Activity In The Liver Disease Diagnostics Market?

The liver disease diagnostics market covered in this report is segmented –

1) By Diagnosis Technique: Laboratory Tests, Imaging, Biopsy, Other Diagnosis Techniques

2) By Disease: Non-Alcoholic Fatty Liver Disease, Non-Alcoholic Steatohepatitis, Fibrosis, Cirrhosis, Hepatocellular Carcinoma, Other Diseases

3) By End Users: Hospitals, Laboratories, Other End Users

Subsegments:

1) By Laboratory Tests: Blood Tests (Liver Function Tests, Hepatitis Panel), Enzyme Tests (ALT, AST, ALP), Serological Tests

2) By Imaging: Ultrasound Imaging, CT Scans, MRI, Elastography (FibroScan)

3) By Biopsy: Liver Biopsy (Needle Biopsy), Fine Needle Aspiration Biopsy, Laparoscopic Biopsy

4) By Other Diagnosis Techniques: Biomarker Testing, Fibrosis Scoring Systems

Which Trends Are Expected To Influence The Liver Disease Diagnostics Market In The Upcoming Years?

Major companies operating in the liver disease diagnostics market are concentrating on developing innovative solutions, such as non-invasive tools for liver assessment, to create more accurate and efficient diagnostic methods. A non-invasive tool for liver assessment refers to diagnostic approaches that evaluate liver conditions through techniques like elastography or blood tests, thus avoiding the necessity for invasive procedures such as biopsies. For instance, in September 2024, City Imaging & Clinical, an India-based diagnostic center, launched FibroScan, a non-invasive diagnostic tool for liver assessment, aimed at the early detection of liver diseases including non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD). This advanced technology facilitates rapid and precise measurements of liver stiffness and fat content without the requirement for invasive procedures like biopsies. The procedure is quick, typically lasting 5 to 15 minutes, involving the placement of a probe on the skin over the liver. The probe emits sound waves, which quantify liver tissue stiffness, aiding in the assessment of fibrosis or scarring.

Which Leading Companies Dominate The Liver Disease Diagnostics Market Share?

Major companies operating in the liver disease diagnostics market are F. Hoffmann-La Roche Ltd., Abbott Laboratories, Thermo Fisher Scientific Inc., Siemens Healthineers AG, Fujifilm Holdings Corporation, Boston Scientific Corporation, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, bioMérieux SA, Echosens SA, Hologic Inc., Canon Medical Systems Corporation, GE HealthCare Technologies Inc., Mindray Bio-Medical Electronics Co. Ltd., Samsung Medison Co. Ltd., Bruker Corporation, Sysmex Corporation, DiaSorin S.p.A., Perspectum Diagnostics Ltd., Owlstone Medical Ltd., HEPQuant LLC, Aiforia Technologies Plc

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/liver-disease-diagnostics-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Liver Disease Diagnostics Market?

North America was the largest region in the liver disease diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the liver disease diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Liver Disease Diagnostics Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20862&type=smp

Browse Through More Reports Similar to the Global Liver Disease Diagnostics Market 2026, By The Business Research Company

Clinical Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/clinical-diagnostics-global-market-report

Hepatitis Diagnostic Tests Market Report 2026

https://www.thebusinessresearchcompany.com/report/hepatitis-diagnostic-tests-global-market-report

Liver Diseases Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/liver-diseases-therapeutics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795